Myomo, Inc. (MYO) Operating Margin
- Operating margin · 12 months: Value -27.05%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -27.05% | Operating income / revenue. Period ending 2026-06-30. $-11.70M ÷ $43.26M × 100 ≈ -27.05% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -11.70M USD | Operating Income (Loss) |
| Revenue | 43.26M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 111.80K USD | Cost of Goods and Services Sold |
| Research and development | 6.50M USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.70M | $43.26M | $111.80K | $6.50M | (m) | -27.05% |
| 2026-03-31 | $-14.04M | $41.21M | $136.20K | $6.78M | (m) | -34.07% |
| 2025-12-31 | $-14.40M | $40.93M | $109.00K | $6.94M | (m) | -35.19% |
| 2025-09-30 | $-11.87M | $41.64M | $182.80K | $6.88M | (m) | -28.51% |
| 2025-06-30 | $-9.31M | $40.76M | $164.40K | $6.60M | (m) | -22.85% |
| 2025-03-31 | $-5.84M | $38.63M | $136.70K | $5.61M | (m) | -15.11% |
| 2024-12-31 | $-6.21M | $32.55M | $216.40K | $4.77M | (m) | -19.07% |
| 2024-09-30 | $-8.39M | $25.24M | (m) | $4.09M | (m) | -33.26% |
| 2024-06-30 | $-9.46M | $21.11M | (m) | $3.56M | (m) | -44.82% |
| 2024-03-31 | $-9.45M | $19.55M | (m) | $3.12M | (m) | -48.34% |
| 2023-12-31 | $-8.23M | $19.24M | (m) | $2.64M | $18.78M | -42.78% |
| 2023-09-30 | $-8.03M | $18.53M | (m) | $2.26M | $18.47M | -43.33% |
| 2023-06-30 | $-8.81M | $17.41M | (m) | $2.23M | $18.44M | -50.60% |
| 2023-03-31 | $-10.60M | $15.13M | (m) | $2.30M | $18.29M | -70.07% |
| 2022-12-31 | $-10.67M | $15.56M | (m) | $2.48M | $18.44M | -68.61% |
| 2022-09-30 | $-11.15M | $15.55M | (m) | $2.77M | $19.13M | -71.72% |
| 2022-08-16 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $-10.36M | $15.96M | (m) | $2.72M | $19.02M | -64.91% |
| 2022-03-31 | $-10.07M | $15.39M | (m) | $2.69M | $18.56M | -65.46% |
| 2021-12-31 | $-10.27M | $13.86M | $112.90K | $2.56M | $18.02M | -74.10% |
| 2021-09-30 | $-9.25M | $13.61M | $214.90K | $2.19M | $17.03M | -67.93% |
| 2021-06-30 | $-9.76M | $11.16M | $382.00K | $1.89M | $15.64M | -87.51% |
| 2021-03-31 | $-10.01M | $8.91M | $466.60K | $1.69M | $14.33M | -112.35% |
| 2020-12-31 | $-10.50M | $7.58M | $457.20K | $1.67M | $13.82M | -138.50% |
| 2020-09-30 | $-11.40M | $5.31M | $507.50K | $2.10M | $13.09M | -214.47% |
| 2020-06-30 | $-11.68M | $3.99M | $443.60K | $2.19M | $12.49M | -292.36% |
| 2020-03-31 | $-11.53M | $4.02M | $484.00K | $2.22M | $12.38M | -287.23% |
| 2019-12-31 | $-10.80M | $3.84M | $490.50K | $2.16M | $11.55M | -281.29% |
| 2019-09-30 | $-10.95M | $3.21M | $471.20K | $2.15M | $11.16M | -341.46% |
| 2019-06-30 | $-10.83M | $3.21M | $533.30K | $2.05M | $11.14M | -337.57% |
| 2019-03-31 | $-10.81M | $2.96M | $513.30K | $2.00M | $10.97M | -365.02% |
| 2018-12-31 | $-10.53M | $2.44M | $530.30K | $1.84M | $10.41M | -430.77% |
| 2018-09-30 | $-9.61M | $2.10M | (m) | $1.67M | $9.34M | -457.17% |
| 2018-06-30 | $-8.34M | $1.98M | (m) | $1.55M | $8.14M | -420.69% |
| 2018-03-31 | $-7.59M | $1.66M | (m) | $1.77M | $6.94M | -458.22% |
| 2017-12-31 | $-6.55M | $1.56M | (m) | $1.75M | $5.85M | -420.06% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-3.28M | $1.10M | (m) | $1.12M | $2.98M | -296.84% |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |